Home » Topics » Regulatory

Regulatory
RSS

Further indications of divalproex efficacy in dementia

Oct. 21, 1997

FDA approves RPR's Nasacort for pediatric use

Oct. 20, 1997

Andrx's Diltia XT approved and launched in U.S.

Oct. 20, 1997

Shire files IND for new formulation of aciclovir

Oct. 20, 1997

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Fujisawa launches new OTC product

Oct. 17, 1997

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

FDA actively reviewing TOBI

Oct. 13, 1997

CellPro seeks new indication for CEPRATE SC System

Oct. 13, 1997

Oral desmopressin evaluated in bed-wetting children

Oct. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...